[11C]SY08 for Dementia With Lewy Bodies and Parkinson's Disease

PET Imaging Evaluation of [11C]SY08

Recruiting Early Phase 1 Interventional Study
Parkinson's Disease Multiple System Atrophy Dementia With Lewy Bodies Healthy Controls
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
40 (estimated)
Sponsor
Massachusetts General Hospital · Other
Who this trial is looking for

This trial is looking for participants aged 50-80 with dementia and certain movement disorders. Involvement includes a PET scan where a small amount of a tracer will be injected to help understand brain function.

Are You a Good Fit for This Trial?
Rules you out Bipolar disorderDrug or alcohol abuse

You may be able to join if

  • I am between 50 and 80 years old.
  • I can give written consent.
  • I can read, speak, and understand English.
  • I am willing to have a PET/MRI scan.
  • I have a diagnosis of Parkinson's disease.
  • I have a diagnosis of multiple system atrophy.
  • I have a diagnosis of dementia with Lewy bodies.
  • I have a study partner who can discuss my daily functioning.

You may not be able to join if

  • I have uncontrolled high blood pressure or cholesterol.
  • I have a major psychiatric condition.
  • I have had a stroke.
  • I have any focal brain lesions.
  • I have had major surgery in the last 6 months.
  • I have a history of significant head trauma.
  • I am pregnant or breastfeeding.
  • I weigh more than 300 lbs.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose of this study is to evaluate the use of \[11C\]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DL…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * General Inclusion criteria, all subjects must: 1. Age 50-80 2. Be able to provide written informed consent or assent 3. Be able to read, speak and understand English (The investigators do not have the resources necessary to properly study non-English speaking patients i…
Contacts

Changning Wang, PhD

6177243983

cwang15@mgh.harvard.edu

CONTACT